• By ICR Secretariat
  • Posted Tuesday, November 1, 2022

Pfizer planning steep price hike for COVID-19 vaccine

https://www.biopharmadive.com/news/pfizer-covid-vaccine-higher-price-commercial-market/634687/

Pfizer is considering hiking the price of its COVID-19 vaccine by roughly four times what it currently charges as it prepares for sales in the U.S. to shift from government contracts to the private market.